Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,364 | 63 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $333.52 | 17 | $0 (2022) |
| Amgen Inc. | $303.19 | 9 | $0 (2017) |
| Lilly USA, LLC | $154.93 | 5 | $0 (2017) |
| Purdue Pharma L.P. | $135.14 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $57.93 | 4 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $51.23 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.77 | 3 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $40.48 | 3 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $37.34 | 3 | $0 (2017) |
| PFIZER INC. | $30.11 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.57 | 4 | ABBVIE INC. ($27.38) |
| 2022 | $49.49 | 1 | Novo Nordisk Inc ($49.49) |
| 2019 | $49.99 | 1 | Novo Nordisk Inc ($49.99) |
| 2018 | $98.61 | 2 | Ferring Pharmaceuticals Inc. ($51.23) |
| 2017 | $1,087 | 55 | Amgen Inc. ($303.19) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: DIABETES | ||||||
| 03/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: VACCINES | ||||||
| 12/01/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: Obesity | ||||||
| 12/05/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 11/29/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $47.38 | General |
| Category: Diabetes | ||||||
| 07/09/2018 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $51.23 | General |
| Category: ORTHOPEDICS | ||||||
| 11/30/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $47.38 | General |
| Category: Diabetes | ||||||
| 09/14/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: Diabetes | ||||||
| 09/14/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: Diabetes | ||||||
| 09/08/2017 | Valeant Pharmaceuticals North America LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROLOGY | ||||||
| 09/06/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/31/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, FLUZONE | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: VACCINES | ||||||
| 08/29/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $99.48 | General |
| Category: Diabetes | ||||||
| 08/29/2017 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| 08/25/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Obesity | ||||||
| 08/23/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/11/2017 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiovascular | ||||||
| 07/19/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug), HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/12/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Obesity | ||||||
| 07/06/2017 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 07/05/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 694 | 819 | $58,354 | $19,941 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $3,680 | $3,309 | 89.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 32 | $8,672 | $2,987 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $6,496 | $2,322 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,371 | $2,260 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,880 | $1,371 | 72.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,674 | $816.36 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 58 | 93 | $1,023 | $781.20 | 76.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 57 | 74 | $3,700 | $765.90 | 20.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 23 | 23 | $3,450 | $667.23 | 19.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 45 | 48 | $3,408 | $629.76 | 18.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 39 | 42 | $2,310 | $620.76 | 26.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 36 | 40 | $2,040 | $576.40 | 28.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 32 | $1,474 | $553.60 | 37.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 46 | 63 | $1,827 | $479.43 | 26.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 22 | 23 | $1,334 | $378.58 | 28.4% |
| 83735 | Magnesium level | Office | 2023 | 33 | 45 | $1,350 | $295.65 | 21.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 17 | 18 | $1,134 | $240.48 | 21.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 20 | $880.00 | $190.40 | 21.6% |
| 83550 | Iron binding capacity | Office | 2023 | 17 | 18 | $720.00 | $154.26 | 21.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 29 | 36 | $900.00 | $151.20 | 16.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 15 | 18 | $666.00 | $142.38 | 21.4% |
| 83540 | Iron level | Office | 2023 | 17 | 18 | $612.00 | $114.12 | 18.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 19 | 23 | $391.00 | $71.53 | 18.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 11 | 11 | $362.00 | $62.26 | 17.2% |
About Dr. Cherrie Hart, MD
Dr. Cherrie Hart, MD is a Family Medicine healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1073774295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cherrie Hart, MD has received a total of $1,364 in payments from pharmaceutical and medical device companies, with $79.57 received in 2024. These payments were reported across 63 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,364).
As a Medicare-enrolled provider, Hart has provided services to 694 Medicare beneficiaries, totaling 819 services with total Medicare billing of $19,941. Data is available for 1 year (2023–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Greenville, NC
- Active Since 06/20/2008
- Last Updated 09/11/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073774295
Products in Payments
- Prolia (Biological) $163.12
- Saxenda (Drug) $161.04
- Repatha (Biological) $140.07
- TRULICITY (Drug) $114.42
- Victoza (Drug) $64.08
- EUFLEXXA (Device) $51.23
- Ozempic (Drug) $47.38
- XARELTO (Drug) $43.52
- TRADJENTA (Drug) $27.44
- QULIPTA (Drug) $27.38
- XIFAXAN (Drug) $24.42
- Horizant (Drug) $23.03
- TRINTELLIX (Drug) $20.71
- STIOLTO (Drug) $19.35
- Edarbi (Drug) $17.45
- Livalo (Drug) $16.68
- JARDIANCE (Drug) $15.93
- PREVNAR 20 (Biological) $15.55
- CONTRAVE (Drug) $14.88
- PREVNAR - 13 (Biological) $14.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greenville
James Franklin, M.d, M.D
Family Medicine — Payments: $114,754
Jeffrey Harris, Md, MD
Family Medicine — Payments: $112,265
Steve Hamberis, M.d, M.D
Family Medicine — Payments: $23,679
Dr. Richard Leland, M.d, M.D
Family Medicine — Payments: $22,628
Dr. Quentin Mewborn, Md, MD
Family Medicine — Payments: $17,870
Eric Faile, M.d, M.D
Family Medicine — Payments: $17,596